0001790236-19-000001.txt : 20191009 0001790236-19-000001.hdr.sgml : 20191009 20191009134102 ACCESSION NUMBER: 0001790236-19-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20191009 DATE AS OF CHANGE: 20191009 EFFECTIVENESS DATE: 20191009 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Arcuate Therapeutics, Inc. CENTRAL INDEX KEY: 0001790236 IRS NUMBER: 842801959 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-350699 FILM NUMBER: 191144241 BUSINESS ADDRESS: STREET 1: 200 BERKELEY STREET, 18TH FLOOR STREET 2: C/O RA CAPITAL CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 617-778-2580 MAIL ADDRESS: STREET 1: 200 BERKELEY STREET, 18TH FLOOR STREET 2: C/O RA CAPITAL CITY: BOSTON STATE: MA ZIP: 02116 D 1 primary_doc.xml X0708 D LIVE 0001790236 Arcuate Therapeutics, Inc. 200 BERKELEY STREET, 18TH FLOOR C/O RA CAPITAL BOSTON MA MASSACHUSETTS 02116 617-778-2580 DELAWARE Renal Co. Inc. None Corporation true 2019 Andrew Levin 200 Berkeley Street, 18th Floor c/o RA Capital Boston MA MASSACHUSETTS 02116 Executive Officer Director Joshua Resnick 200 Berkeley Street, 18th Floor c/o RA Capital Boston MA MASSACHUSETTS 02116 Director Aaron Bergener 200 Berkeley Street, 18th Floor c/o RA Capital Boston MA MASSACHUSETTS 02116 Executive Officer James Schneider 200 Berkeley Street, 18th Floor c/o RA Capital Boston MA MASSACHUSETTS 02116 Executive Officer Sarah Reed 200 Berkeley Street, 18th Floor c/o RA Capital Boston MA MASSACHUSETTS 02116 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2019-09-27 true true false 0 10000002 5000001 5000001 false 3 0 0 0 false Arcuate Therapeutics, Inc. Andrew Levin Andrew Levin President 2019-10-09